Synthesis and broad spectrum antiviral evaluation of bis(POM) prodrugs of novel acyclic nucleosides

•The synthesis of new acyclonucleoside phosphonates is proposed.•Challenging olefin acyclic cross metathesis is the key synthetic step.•CuAAC reaction under microwave activation led to substituted-1,2,3-triazoles.•Compounds exhibited pronounced anti-HCV activity.•Compounds were also evaluated on a wide panel of other viral strains.

A series of seventeen hitherto unknown ANP analogs bearing the (E)-but-2-enyl aliphatic side chain and modified heterocyclic base such as cytosine and 5-fluorocytosine, 2-pyrazinecarboxamide, 1,2,4-triazole-3-carboxamide or 4-substituted-1,2,3-triazoles were prepared in a straight approach through an olefin acyclic cross metathesis as key synthetic step.All novel compounds were evaluated for their antiviral activities against a large number of DNA and RNA viruses including herpes simplex virus type 1 and 2, varicella zoster virus, feline herpes virus, human cytomegalovirus, hepatitis C virus (HCV), HIV-1 and HIV-2. Among these molecules, only compound 31 showed activity against human cytomegalovirus in HEL cell cultures with at EC50 of ∼10 μM. Compounds 8a, 13, 14, and 24 demonstrated pronounced anti-HCV activity without significant cytotoxicity at 100 μM.

Graphical abstractSeventeen ANP bearing the (E)-but-2-enyl side chain with cytosine, 5-fluorocytosine, 2-pyrazinecarboxamide, 1,2,4-triazole-3-carboxamide and 4-substituted-1,2,3-triazoles were prepared through challenging olefin acyclic cross metathesis. Some pronounced anti-HCV activity were found.Figure optionsDownload full-size imageDownload as PowerPoint slide